
Keywords: تب هموراژیک; Ebola virus; Hemorrhagic fever; Viral life cycle modeling system; Drug screening; FDA drugs; Repurposing; EBOV; Ebola virus; EVD; EBOV disease; VHF; Viral hemorrhagic fever; trVLP; transcription- and replication-competent virus-like particle; HTS; High-th